Collegium Pharmaceutical (COLL) Amortization - Intangibles (2019 - 2025)
Collegium Pharmaceutical has reported Amortization - Intangibles over the past 7 years, most recently at $55.5 million for Q4 2025.
- Quarterly results put Amortization - Intangibles at $55.5 million for Q4 2025, changed 0.0% from a year ago — trailing twelve months through Dec 2025 was $221.9 million (up 34.23% YoY), and the annual figure for FY2025 was $221.9 million, up 34.23%.
- Amortization - Intangibles for Q4 2025 was $55.5 million at Collegium Pharmaceutical, roughly flat from $55.5 million in the prior quarter.
- Over the last five years, Amortization - Intangibles for COLL hit a ceiling of $55.5 million in Q1 2025 and a floor of $16.8 million in Q1 2021.
- Median Amortization - Intangibles over the past 5 years was $37.5 million (2023), compared with a mean of $36.8 million.
- Biggest five-year swings in Amortization - Intangibles: soared 151.74% in 2022 and later fell 18.37% in 2023.
- Collegium Pharmaceutical's Amortization - Intangibles stood at $16.8 million in 2021, then soared by 151.74% to $42.3 million in 2022, then dropped by 18.37% to $34.5 million in 2023, then soared by 60.72% to $55.5 million in 2024, then increased by 0.0% to $55.5 million in 2025.
- The last three reported values for Amortization - Intangibles were $55.5 million (Q4 2025), $55.5 million (Q3 2025), and $55.5 million (Q2 2025) per Business Quant data.